Kogieleum Naidoo
Kogieleum Naidoo | |
|---|---|
| Occupations | Researcher, Academic |
| Academic background | |
| Alma mater | University of Kwazulu-Natal |
| Academic work | |
| Discipline | tuberculosis-HIV research |
| Institutions | CAPRISA |
Kogieleum Naidoo is a South African scientist, researcher and academic at University of KwaZulu-Natal. Her research work has a focus on the HIV & AIDS infection with focus advancing care for individuals affected by Tuberculosis and AIDS.
Education
Kogieleum Naidoo has a MBChB in Medicine and Surgery.[1]
She obtained her PhD from University of KwaZulu-Natal: Durban, within the period of February, 2012 to 14 April 2016.[2]
Career
Kogieleum Naidoo has worked in various capactites from academic, research, and administrative positions.
University of KwaZulu-Natal: Durban
- Department of Obstetrics and Gynaecology, Pregnancy Hypertension Research Unit -1994
- Clinical Investigator – Paediatric Transmission of AIDS (Petra) Department of Obstetrics and Gynaecology - 1996 - 2000
- Clinical investigator – South African Intrapartum Nevirapine (SAINT) Study (Department of Obstetrics and Gynaecology) - 1999 - 2000[2]
King Edward VIII Hospital: Durban
- Medical Intern - 1993 - 1994
- Medical Officer (Department of Paediatrics) - 1995 -1996
- Medical Officer (Department of Medicine, University of KwaZulu-Natal) - 2001[2]
Centre for the AIDS Program of Research in South Africa(CAPRISA)
- Project Director (START study and CAPRISA AIDS Treatment Programme) - 2005
- Head (Treatment Research Programme) - 2007 - 31/10/2024
- Deputy Director and Head of eThekwini CAPRISA Research Clinic (ECRS) - present[3]
Publications
- Recurrent Subclinical Tuberculosis Among Antiretroviral Therapy–Accessing Participants: Incidence, Clinical Course, and Outcomes [4]
- The epidemiology, transmission, diagnosis, and management of drug-resistant tuberculosis-lessons from the South African experience[5]
- Clinical evaluation of SARS-CoV-2 rapid antigen tests during the Omicron wave in South Africa[6]
Recognition
References
- ↑ "Professor Kogieleum Naidoo, MBChB, PhD | The AAS". aasciences.africa. Retrieved 2025-08-15.
- 1 2 3 4 "ORCID". orcid.org. Retrieved 2025-08-15.
- ↑ "Kogie Naidoo". The Conversation. 2020-07-13. Retrieved 2025-08-15.
- ↑ Naidoo, Kogieleum; Moodley, Mikaila C.; Hassan-Moosa, Razia; Dookie, Navisha; Yende-Zuma, Nonhlanhla; Perumal, Rubeshan; Dawood, Halima; Mvelase, Nomonde R.; Mathema, Barun; Karim, Salim Abdool (2022). "Recurrent Subclinical Tuberculosis Among Antiretroviral Therapy–Accessing Participants: Incidence, Clinical Course, and Outcomes". Clinical Infectious Diseases. 75 (9): 1628–1636. doi:10.1093/cid/ciac185. PMC 9617574. PMID 35247054.
- ↑ Naidoo, Kogieleum; Perumal, Rubeshan; Cox, Helen; Mathema, Barun; Loveday, Marian; Ismail, Nazir; Omar, Shaheed Vally; Georghiou, Sophia B.; Daftary, Amrita; O'Donnell, Max; Ndjeka, Norbert (September 2024). "The epidemiology, transmission, diagnosis, and management of drug-resistant tuberculosis-lessons from the South African experience". The Lancet. Infectious Diseases. 24 (9): e559–e575. doi:10.1016/S1473-3099(24)00144-0. ISSN 1474-4457. PMID 38527475.
- ↑ "Clinical evaluation of SARS-CoV-2 rapid antigen tests during the Omicron wave in South Africa".
- ↑ "UKZN NdabaOnline". ndabaonline.ukzn.ac.za. Archived from the original on 2023-01-31. Retrieved 2025-08-15.
- ↑ "Professor Kogieleum Naidoo receives the Outstanding Female Scientist Prize". EDCTP. Retrieved 2025-08-15.